• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The management of recurrent ovarian cancer.

作者信息

Bukowski Ronald M, Ozols Robert F, Markman Maurie

机构信息

The Cleveland Clinic Foundation Taussig Cancer Center, Cleveland Clinic Foundation Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

出版信息

Semin Oncol. 2007 Apr;34(2 Suppl 2):S1-15. doi: 10.1053/j.seminoncol.2007.03.012.

DOI:10.1053/j.seminoncol.2007.03.012
PMID:17512352
Abstract
摘要

相似文献

1
The management of recurrent ovarian cancer.复发性卵巢癌的管理
Semin Oncol. 2007 Apr;34(2 Suppl 2):S1-15. doi: 10.1053/j.seminoncol.2007.03.012.
2
Ovarian cancer: a focus on management of recurrent disease.卵巢癌：聚焦复发性疾病的管理
Nat Clin Pract Oncol. 2006 Nov;3(11):604-11. doi: 10.1038/ncponc0637.
3
[Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms].
Zhonghua Fu Chan Ke Za Zhi. 2010 Nov;45(11):801-3.
4
[Therapy for ovarian cancer--general review].[卵巢癌治疗——综述]
Nihon Rinsho. 2004 Oct;62 Suppl 10:517-21.
5
New developments in the management of ovarian cancer.卵巢癌治疗的新进展
J Med Assoc Ga. 2003 Winter-Spring;92(1):23-6, 33.
6
Ovarian cancer.卵巢癌
J Indian Med Assoc. 2012 Dec;110(12):894-7.
7
Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.晚期卵巢癌的二线铂类腹腔内化疗
Acta Obstet Gynecol Scand. 2009;88(4):463-7. doi: 10.1080/00016340902777525.
8
Ovarian cancer: strategies for overcoming resistance to chemotherapy.卵巢癌：克服化疗耐药性的策略
Nat Rev Cancer. 2003 Jul;3(7):502-16. doi: 10.1038/nrc1123.
9
Cancer ovary, present and future of management.
J Ayub Med Coll Abbottabad. 2003 Apr-Jun;15(2):65-8.
10
Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.复发性卵巢癌的现代管理。一种针对慢性病的系统方法。
Oncology (Williston Park). 2005 Sep;19(10):1277-85; discussion 1285, 1288, 1293.

引用本文的文献

1
IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer.胰岛素样生长因子1受体（IGF1R）抑制与程序性死亡受体1（PD-1）阻断可改善上皮性卵巢癌的抗肿瘤免疫反应。
Front Oncol. 2024 Oct 10;14:1410447. doi: 10.3389/fonc.2024.1410447. eCollection 2024.
2
Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis.原发性和转移性卵巢高级别浆液性癌中PD-L1表达的不一致性及其与CD8⁺肿瘤浸润淋巴细胞和患者预后的相关性。
Virchows Arch. 2023 Apr;482(4):755-766. doi: 10.1007/s00428-023-03512-x. Epub 2023 Feb 21.
3
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.
每周紫杉醇联合卡铂与每 3 周紫杉醇联合卡铂一线治疗上皮性卵巢癌的疗效比较。
Cochrane Database Syst Rev. 2022 Feb 21;2(2):CD012007. doi: 10.1002/14651858.CD012007.pub2.
4
Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1.卵巢癌的免疫疗法：超越PD-1/PD-L1的思考
Front Oncol. 2021 Dec 13;11:795547. doi: 10.3389/fonc.2021.795547. eCollection 2021.
5
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.ZYG11A 在卵巢上皮性癌中表达，并与低级别疾病相关。
Front Endocrinol (Lausanne). 2021 Jun 18;12:688104. doi: 10.3389/fendo.2021.688104. eCollection 2021.
6
IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer.胰岛素样生长因子1受体（IGF1R）轴抑制可恢复卵巢癌中树突状细胞的抗肿瘤反应。
Transl Oncol. 2020 Aug;13(8):100790. doi: 10.1016/j.tranon.2020.100790. Epub 2020 May 16.
7
Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview.巨噬细胞极化在卵巢癌发生发展中的研究综述
Front Oncol. 2019 May 22;9:421. doi: 10.3389/fonc.2019.00421. eCollection 2019.
8
VISTA expressed in tumour cells regulates T cell function.肿瘤细胞中表达的 VISTA 调节 T 细胞功能。
Br J Cancer. 2019 Jan;120(1):115-127. doi: 10.1038/s41416-018-0313-5. Epub 2018 Nov 9.
9
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.EMSY基因表达及多态性在卵巢癌中的临床意义。
Oncotarget. 2018 Apr 3;9(25):17735-17755. doi: 10.18632/oncotarget.24878.
10
Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.卵巢癌中与铂类药物再敏感相关的基因组和表观基因组特征。
Cancer Res. 2018 Feb 1;78(3):631-644. doi: 10.1158/0008-5472.CAN-17-1492. Epub 2017 Dec 11.